Dexamethasone, High-Dose Cytarabine, and Cisplatin in Combination with Rituximab as Salvage Treatment for Patients with Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma-Reference-Cited by-同舟云学术

Dexamethasone, High-Dose Cytarabine, and Cisplatin in Combination with Rituximab as Salvage Treatment for Patients with Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Published:2006-01 Issue:6 Volume:24 Page:593-600
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Mey Ulrich J. M.,Orlopp Katjana S.,Flieger Dimitri,Strehl John W.,Ho Anthony D.,Hensel Manfred,Bopp Cordula,Gorschlüter Marcus,Wilhelm Martin,Birkmann Josef,Kaiser Ulrich,Neubauer Andreas,Florschütz Axel,Rabe Christian,Hahn Corinna,Glasmacher Axel G.,Schmidt-Wolf Ingo G. H.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/07357900600814490

Reference34 articles.

1. A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: Results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study

2. Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

3. The Role of Intensive Therapy and Autologous Blood and Marrow Transplantation for Chemotherapy‐Sensitive Relapsed and Primary Refractory Non‐Hodgkin’s Lymphoma: Identification of Major Prognostic Groups

4. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A paradox of choice: Sequencing therapy in relapsed/refractory diffuse large B-cell lymphoma;Blood Reviews;2024-01

2. Advances in Polatuzumab Vedotin-PIIQ Therapy: A Review of Treatment Efficacy in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma;Pediatric Health, Medicine and Therapeutics;2023-10

3. Polatuzumab Vedotin in a Patient with Refractory Burkitt Lymphoma, a Case Report;OncoTargets and Therapy;2023-02

4. Lisocabtagene maraleucel for relapsed or refractory large B-cell non-Hodgkin lymphoma;Expert Review of Anticancer Therapy;2023-01-24

5. Cancers of the Blood;Fundamentals of Cancer Detection, Treatment, and Prevention;2022-05-13